Summary of NEURALSTEM, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

CUR > SEC Filings for CUR > Form 8-K on 16-Jan-2013

All Recent SEC Filings

Show all filings for NEURALSTEM, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for NEURALSTEM, INC.

16-Jan-2013

Other Events

Item 8.01. Other Events.

On January 14, 2013, Neuralstem, Inc. ("Company") announced that it received approval from the United States Food and Drug Administration (FDA) to commence Phase I safety trial of NSI-566 in chronic spinal cord injury patients. A copy of the press release is attached to this report as Exhibit 99.01.

Add CUR to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for CUR - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.